A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer - Sorbonne Université
Article Dans Une Revue Gynecologic Oncology Année : 2023

A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer

Domaines

Cancer

Dates et versions

hal-04210315 , version 1 (18-09-2023)

Identifiants

Citer

Félix Blanc-Durand, Elisa Yaniz-Galende, Alba Llop-Guevara, Catherine Genestie, Violeta Serra, et al.. A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer. Gynecologic Oncology, 2023, 171, pp.106-113. ⟨10.1016/j.ygyno.2023.01.026⟩. ⟨hal-04210315⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

More